Treatment of Borderline Personality Disorder With rTMS — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Treatment of Borderline Personality Disorder With rTMS — Stella

Recruiting

Back to Borderline Personality Disorder trials

Not a traditional drug trial — this study doesn't follow the standard phase structure.

Trial locations(2 sites)

United States

Semel Institute for Neuroscience and Human Behavior at UCLA, Los Angeles, California

Semel Institute/ UCLA TMS, Los Angeles, California

Key details

Sponsor

University of California, Los Angeles

Enrollment target

~30 participants

Started

March 2025

Primary completion

December 2027

Age range

18 Years – 65 Years

Last updated October 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Follow this trial

Get notified in plain English when this trial's status changes. No account required.

View full record on ClinicalTrials.gov